Cartilage damaging activities of fibronectin fragments derived from cartilage and synovial fluid

Osteoarthritis and Cartilage

Volumn 6, Issue 4, 1998, Pages 231-244

  Homandberg, Gene A ^a   Wen, Catherine ^a   Hui, Francis ^a  

^a RUSH MEDICAL COLLEGE   (United States)

Author keywords

Cartilage; Damage; Fibronectin; Fragments; Proteases; Proteoglycan

Indexed keywords

FIBRONECTIN;

ARTICLE; ARTICULAR CARTILAGE; BIOTINYLATION; CARTILAGE DEGENERATION; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

EID: 0032127059     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1053/joca.1998.0116     Document Type: Article

References (35)

1. 1. Carnemolla B, Cutolo M, Castellani P, Balza E, Raffanti S, Zardi L. Characterization of synovial fluid fibronectin from patients with inflammatory diseases and healthy subjects. Arthritis Rheum. 1984;27:913-21.
2. 2. Carsons S, Lavietes BB, Diamond HS, Kinney SG. The immunoreactivity, ligand and cell binding characteristics of rheumatoid synovial fluid fibronectin. Arthritis Rheum. 1985;28:601-12.
3. 3. Griffiths AM, Herbert KE, Perrett D, Scott DL. Fragmented fibronectin and other synovial fluid proteins in chronic arthritis: their relation to immune complexes. Clinica Chimica Acta. 1989;184:133-46.
4. 4. Dutu A, Vlaicu-Rus V, Bolosiu HD, Parasca I, Cristea A. Fibronectin in plasma and synovial fluid of patients with rheumatic diseases. Med Interne. 1986;24:61-8.
5. 5. Xie DL, Meyers R, Homandberg GA. Fibronectin fragments in osteoarthritic synovial fluids. J. Rheumatol. 1992;19:1448-52.
6. 6. Homandberg GA, Meyers R, Xie DL. Fibronectin fragments cause chondrolysis of bovine articular cartilage slices in culture. J. Biol. Chem. 1992;267:3597-604.
7. 7. Xie DL, Hui F, Homandberg GA. Fibronectin fragments reversibly alter matrix protein synthesis in cartilage in vitro. Arch Biochem Biophys. 1993;307:110-8.
8. 8. Homandberg GA, Meyers R, Williams JM. Intraarticular injection of fibronectin fragments induces cartilage proteoglycan release. J. Rheumatol. 1993;20:1378-82.
9. 9. Xie DL, Homandberg GA. Fibronectin fragments bind and penetrate cartilage tissue resulting in protease expression and cartilage damage. Biochim Biophys Acta 1993;1182:189-96.
10. 10. Homandberg GA, Hui F. Arg-Gly-Asp-Ser analogs suppress cartilage chondrolysis activities of integrin-binding and non-binding fibronectin fragments. Arch Biochem Biophys. 1994;310:40-8.
11. 11. Homandberg GA, Hui F, Wen C, Purple C, Bewsey K, Koepp H, Huch K, Harris A. Fibronectin fragment induced cartilage chondrolysis is associated with release of catabolic cytokines. Biochem J. 1997;321:751-7.
12. 12. Homandberg GA, Hui F. Fibronectin fragments cause release of both anabolic and catabolic factors from cartilage tissue in vitro. Trans Orthop Res Soc. 1994;19:464a.
13. 13. Xie DL, Hui F, Homandberg GA. Cartilage chondrolysis by fibronectin fragments is associated with release of several proteinases; stromelysin plays a major role in chondrolysis. Arch Biochem Biophys. 1994;311:205-12.
14. 14. Bewsey K, Wen C, Purple C, Homandberg GA. Fibronectin fragments induce the expression of stromelysin-1 mRNA and protein in bovine chondrocytes in monolayer culture. Biochim Biophys Acta 1996;1317:55-64.
15. 15. Homandberg GA, Hui F, Wen C. Association of proteoglycan degradation with catabolic cytokine and stromelysin release from cartilage cultured with fibronectin fragments. Arch. Biochem. Biophys. 1986;334:325-31.
16. 16. Murphy J, Cawston TE, Galloway WA, Barnes MJ, Bunning RAD, Mercer E, Reynolds JJ, Burgeson RE. Metalloproteinases from rabbit bone culture medium degrades types IV and V collagens, laminin and fibronectin. Biochem J. 1981;199:807-11.
17. 17. Okada Y, Nagase H, Harris Jr ED. A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. J. Biol. Chem. 1986;261:14245-55.
18. 18. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper TA, Jr et al. The American Rheumatology Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-24.
19. 19. Koklitis PA, Murphy G, Sutton C, Angal S. Purification of recombinant human prostromelysin. Studies on heat activation to give high-Mr and low-Mr active forms, and a comparison of recombinant with natural stromelysin activities. Biochem J. 1991;276:217-21.
20. 20. Homandberg GA, Erickson J. A model of fibronectin tertiary structure based on studies of interactions between fragments. Biochemistry 1986;25:6917-25.
21. 21. Hayashi T, Abe E, Jasin HE. Fibronectin synthesis in superficial and deep layers of normal articular cartilage. Arthrit Rheum. 1996;39:567-73.
22. 22. Burton-Wurster N, Lust G. Synthesis of fibronectin in normal and osteoarthritic articular cartilage. Biochim Biophys Acta 1984;800:52-8.
23. 23. Ljubimov AV, Afanasjeva AV, Litvinova LV, Senin VM. 6Basement membrane components produced by a mouse ascites teratocarcinoma TB24. Analysis with monoclonal and polyclonal antibodies. Exp Cell Res. 1986;165:530-40.
24. 24. Horiguchi Y, Fine JD, Ljubimov AV, Yamasaki H, Couchman JR. Entactin: ultrastructural localization of an ubiquitous basement membrane glycoprotein in mouse skin. Arch Dermatol Res. 1989;281:427-32.
25. 25. Fukai, F., Ohtaki M, Fujii N, Yajima H, Ishii T, Nishizawa Y, Miyazaki K, Katayama T. Release of biological activities from quiescent fibronectin by a conformational change and limited proteolysis by matrix metalloproteinases. Biochemistry 1995;34:11453-59.
26. 26. Cawston TE, Bigg HF, Clark IM, Hazleman BL. Identifcation of tissue inhibitor of metalloproteinase-2 (TIMP-2)-progelatinase complex as the third metalloproteinase inhibitor peak in rheumatoid synovial fluid. Ann Rheum Dis. 1993;52:177-81.
27. 27. Clark IM, Powell LK, Ramsey S, Hazleman BL, Cawston TE. The measurement of collagenase, tissue inhibitor of metalloprotienases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 1993;36:372-9.
28. 28. Homandberg GA, Hui F. High concentrations of fibronectin fragments cause short term catabolic effects in cartilage tissue while lower concentrations cause continuous anabolic effects. Arch Biochem Biophys. 1994;311:213-8.
29. 29. Burton-Wurster N, Leipold HR, Lust GR. Dibutyryl cyclic AMP decreases expression of ED-A fibronectin by canine chondrocytes. Biochem Biophys Res Commun. 1988;15:1088-93.
30. 30. Burton-Wurster N, Lust G. Molecular and immunologic differences in canine fibronectins from articular cartilage and plasma. Arch Biochem Biophys. 1989;269:32-45.
31. 31. Bennett VD, Pallante KM, Adams SL. The splicing pattern of fibronectin mRNA changes during chondrogenesis resulting in an unusual form of the mRNA in cartilage. J Biol Chem. 1991;266: 5918-24.
32. 32. Rencic A, Gehris AL, Lewis SD, Hume EL, Bennett VD. 5Splicing patterns of fibronectin mRNA fron normal and osteoarthritic human articular cartilage. Osteoarthritis and Cartilage 1995;3:187-96.
33. 33. Zhang DW, Burton-Wurster N, Lust G. Alternative splicing of ED-A and ED-B sequences of fibronectin pre-mRNA differs in chondrocytes from different cartilaginous tissues and can be modulated by biological factors. J Biol Chem. 1995;270:1817-22.
34. 34. MacLeod JN, Burton-Wurster N, Gu DN, Lust G. Fibronectin mRNA splice variant in articular cartilage lacks bases encoding the V, III-15 and I-10 protein segments. J Biol Chem. 1996;271:18954-60.
35. 35. Burton-Wurster N, Lust G, MacLeod JN. Cartilage fibronectin isoforms: in search of functions for a special population of matrix glycoproteins. Matrix Biol. 1997;15:441-54.